DNAJC2

gene
On this page

Also known as MPP11MPHOSPH11ZUO1zuotin

Summary

DNAJC2 (DnaJ heat shock protein family (Hsp40) member C2, HGNC:13192) is a protein-coding gene on chromosome 7q22.1, encoding DnaJ homolog subfamily C member 2 (Q99543). Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus.

This gene is a member of the M-phase phosphoprotein (MPP) family. The gene encodes a phosphoprotein with a J domain and a Myb DNA-binding domain which localizes to both the nucleus and the cytosol. The protein is capable of forming a heterodimeric complex that associates with ribosomes, acting as a molecular chaperone for nascent polypeptide chains as they exit the ribosome. This protein was identified as a leukemia-associated antigen and expression of the gene is upregulated in leukemic blasts. Also, chromosomal aberrations involving this gene are associated with primary head and neck squamous cell tumors. This gene has a pseudogene on chromosome 6. Alternatively spliced variants which encode different protein isoforms have been described.

Source: NCBI Gene 27000 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 81 total
  • MANE Select transcript: NM_014377

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13192
Approved symbolDNAJC2
NameDnaJ heat shock protein family (Hsp40) member C2
Location7q22.1
Locus typegene with protein product
StatusApproved
AliasesMPP11, MPHOSPH11, ZUO1, zuotin
Ensembl geneENSG00000105821
Ensembl biotypeprotein_coding
OMIM605502
Entrez27000

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 6 protein_coding, 5 retained_intron, 1 nonsense_mediated_decay

ENST00000249270, ENST00000379257, ENST00000379263, ENST00000412522, ENST00000426036, ENST00000454277, ENST00000464253, ENST00000475065, ENST00000475090, ENST00000483637, ENST00000492497, ENST00000915316

RefSeq mRNA: 4 — MANE Select: NM_014377 NM_001129887, NM_001362667, NM_001362668, NM_014377

CCDS: CCDS43628, CCDS47679

Canonical transcript exons

ENST00000379263 — 17 exons

ExonStartEnd
ENSE00000881669103341764103341954
ENSE00001530457103344559103344767
ENSE00001600304103322511103322632
ENSE00001628196103322703103322794
ENSE00003460086103326543103326684
ENSE00003464847103312289103312643
ENSE00003497042103315988103316088
ENSE00003500195103316830103317014
ENSE00003501070103327656103327754
ENSE00003594972103337736103337811
ENSE00003613992103323598103323663
ENSE00003625802103312947103313101
ENSE00003628578103315764103315871
ENSE00003650531103321932103322081
ENSE00003656999103319609103319678
ENSE00003671914103319756103319844
ENSE00003686219103324482103324562

Expression profiles

Bgee: expression breadth ubiquitous, 296 present calls, max score 96.10.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 29.4374 / max 383.0341, expressed in 1819 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
8537527.62531817
853761.8121944

Top tissues by expression

297 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548896.10gold quality
tendon of biceps brachiiUBERON:000818894.33gold quality
gluteal muscleUBERON:000200093.92gold quality
nasal cavity epitheliumUBERON:000538493.77gold quality
cartilage tissueUBERON:000241893.47gold quality
hair follicleUBERON:000207393.45gold quality
tongue squamous epitheliumUBERON:000691993.43gold quality
cervix squamous epitheliumUBERON:000692293.38gold quality
tendonUBERON:000004393.09gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099192.90gold quality
cervix epitheliumUBERON:000480192.42gold quality
calcaneal tendonUBERON:000370192.39gold quality
spermCL:000001992.24gold quality
monocyteCL:000057692.05gold quality
mononuclear cellCL:000084292.03gold quality
mucosa of paranasal sinusUBERON:000503092.02gold quality
epithelial cell of pancreasCL:000008392.00gold quality
superficial temporal arteryUBERON:000161492.00gold quality
male germ cellCL:000001591.99gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047391.96gold quality
left testisUBERON:000453391.89gold quality
testisUBERON:000047391.84gold quality
mucosa of sigmoid colonUBERON:000499391.79gold quality
mucosa of urinary bladderUBERON:000125991.78gold quality
gastrocnemiusUBERON:000138891.55gold quality
nasal cavity mucosaUBERON:000182691.45gold quality
leukocyteCL:000073891.44gold quality
oviduct epitheliumUBERON:000480491.36gold quality
colonic epitheliumUBERON:000039791.29gold quality
epithelium of nasopharynxUBERON:000195191.28gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7606no1175.72
E-MTAB-11011no229.98
E-MTAB-6386no142.11
E-ANND-3no0.00

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

1 targets.

TargetRegulation
PRC1

Literature-anchored findings (GeneRIF, showing 16)

  • concluded that Mpp11, an ortholog of yeast Zuo, is a ribosome-associated J protein; proposed that in metazoans, ribosome-associated Zuo and Mpp11 orthologs recruit cytosolic Hsc70 to short ribosome-bound nascent chains as they exit the ribosome (PMID:15802566)
  • MPP11 is localized to the cytosol and with Hsp70L1, forms the mammalian ribosome-associated complex. (PMID:16002468)
  • describe a novel epitope derived from the MPP11 antigen that has been recognized by human CD8+ CTL (PMID:20231810)
  • At the onset of differentiation, ZRF1 specifically displaces polycomb-repressive complex 1 (PRC1) from chromatin and facilitates transcriptional activation (PMID:21179169)
  • the majority of AML patients elicited a humoral immune response against the tumor antigen MPP11 (PMID:22433847)
  • ZRF1 regulates the INK4-ARF locus during cellular proliferation and senescence, and alterations in ZRF1 may contribute to tumorigenesis. (PMID:22733129)
  • our data reveal that ZRF1 is a key transcriptional regulator in leukemia progression (PMID:24292673)
  • Zrf1 plays an essential role in neural progenitor cell generation and maintenance (PMID:24449271)
  • Zrf1 is transcriptional regulator of neural fate downstream of Id1 in embryonic stem cells.During embryonic stem cell differentiation, Id1 levels decrease allowing Zrf1 to activate neural genes. (PMID:25361733)
  • ZRF1 mediates remodeling of this E3 ligase complex directly at the DNA lesion site. (PMID:27091446)
  • Unexplored functions of ZRF1-mediated remodeling in replication and double strand break repair are discussed. (PMID:27599465)
  • The antibody response to ZRF1 was higher in sera of patients with invasive ductal carcinoma than in sera of patients with other histological types of breast tumors. (PMID:27847402)
  • In response to UV irradiation, DICER is recruited to chromatin in a ZRF1-mediated manner. The H2A-ubiquitin binding protein ZRF1 and DICER together impact on the chromatin conformation via PARP1. (PMID:28402505)
  • These findings suggest that ZRF1 plays a crucial role in tumor malignant potential through its overexpression and highlight its usefulness as a prognostic factor and potential therapeutic target in gastric cancer (PMID:29228320)
  • DNAJC2 is reversely regulated by miR6273p, promoting the proliferation of colorectal cancer. (PMID:34165158)
  • p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation. (PMID:34579723)

Cross-species orthologs

11 orthologs

OrganismSymbolGene ID
danio_reriodnajc2ENSDARG00000070477
mus_musculusDnajc2ENSMUSG00000029014
rattus_norvegicusDnajc2ENSRNOG00000012392
drosophila_melanogasterCG10565FBGN0037051
drosophila_melanogasterl(3)80FgFBGN0287183
caenorhabditis_elegansWBGENE00001020
caenorhabditis_elegansWBGENE00001025
caenorhabditis_elegansWBGENE00001026
caenorhabditis_elegansWBGENE00001029
caenorhabditis_elegansdnj-28WBGENE00001046
caenorhabditis_elegansWBGENE00008122

Paralogs (20): DNAJC11 (ENSG00000007923), DNAJC25 (ENSG00000059769), DNAJC10 (ENSG00000077232), DNAJC5 (ENSG00000101152), DNAJC3 (ENSG00000102580), DNAJC17 (ENSG00000104129), DNAJC12 (ENSG00000108176), DNAJC4 (ENSG00000110011), DNAJC16 (ENSG00000116138), DNAJC14 (ENSG00000135392), DNAJC1 (ENSG00000136770), DNAJC13 (ENSG00000138246), DNAJC5B (ENSG00000147570), DNAJC5G (ENSG00000163793), DNAJC7 (ENSG00000168259), DNAJC21 (ENSG00000168724), DNAJC18 (ENSG00000170464), DNAJC24 (ENSG00000170946), DNAJC30 (ENSG00000176410), DNAJC9 (ENSG00000213551)

Protein

Protein identifiers

DnaJ homolog subfamily C member 2Q99543 (reviewed: Q99543)

Alternative names: M-phase phosphoprotein 11, Zuotin-related factor 1

All UniProt accessions (5): Q99543, C9IZ83, F2Z3H0, F2Z3N9, H7C3L7

UniProt curated annotations — full annotation on UniProt →

Function. Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus. When cytosolic, acts as a molecular chaperone: component of the ribosome-associated complex (RAC), a complex involved in folding or maintaining nascent polypeptides in a folding-competent state. In the RAC complex, stimulates the ATPase activity of the ribosome-associated pool of Hsp70-type chaperones HSPA14 that bind to the nascent polypeptide chain. When nuclear, mediates the switching from polycomb-repressed genes to an active state: specifically recruited at histone H2A ubiquitinated at ‘Lys-119’ (H2AK119ub), and promotes the displacement of the polycomb PRC1 complex from chromatin, thereby facilitating transcription activation.

Subunit / interactions. Component of ribosome-associated complex (RAC), a heterodimer composed of Hsp70/DnaK-type chaperone HSPA14 and Hsp40/DnaJ-type chaperone DNAJC2. Interacts (via ZRF1-UBD region) with ID1.

Subcellular location. Nucleus. Cytoplasm. Cytosol.

Tissue specificity. Widely expressed.

Post-translational modifications. Phosphorylated in M (mitotic) phase.

Domain organisation. The ZRF1-UBD region specifically recognizes and binds H2AK119ub. The ZRF1-UBD region is also involved in protein-protein interactions with other proteins, suggesting that it may be masked by some regulator, thereby preventing its association with H2AK119ub.

Induction. Expression is repressed by CEBPA. Strongly overexpressed in leukemic cells.

Miscellaneous. Constitutes a myeloid leukemia-associated antigen and might be a target for leukemia T-cell therapy.

Isoforms (2)

UniProt IDNamesCanonical?
Q99543-11yes
Q99543-22

RefSeq proteins (4): NP_001123359, NP_001349596, NP_001349597, NP_055192* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001005SANT/MybDomain
IPR001623DnaJ_domainDomain
IPR009057Homeodomain-like_sfHomologous_superfamily
IPR017884SANT_domDomain
IPR017930Myb_domDomain
IPR018253DnaJ_domain_CSConserved_site
IPR032003RAC_headDomain
IPR036869J_dom_sfHomologous_superfamily
IPR042569RAC_head_sfHomologous_superfamily
IPR044634Zuotin/DnaJC2Family
IPR054076ZUO1-like_ZHDDomain

Pfam: PF00226, PF16717, PF21884, PF23082

UniProt features (28 total): helix 7, modified residue 5, region of interest 4, sequence conflict 3, domain 3, chain 2, initiator methionine 1, splice variant 1, mutagenesis site 1, turn 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
2M2ESOLUTION NMR
6CGHSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q99543-F185.510.56

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (5): 1, 47, 49, 60, 63

Mutagenesis-validated functional residues (1):

PositionPhenotype
512–513loss of function.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-3371453Regulation of HSF1-mediated heat shock response

MSigDB gene sets: 173 (showing top): RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT, PUJANA_CHEK2_PCC_NETWORK, GOBP_PROTEIN_MATURATION, ONKEN_UVEAL_MELANOMA_UP, GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, DER_IFN_BETA_RESPONSE_UP, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOBP_PROTEIN_FOLDING, GOBP_DNA_BIOSYNTHETIC_PROCESS, GOBP_CELLULAR_RESPONSE_TO_HEAT, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS

GO Biological Process (7): DNA replication (GO:0006260), regulation of translational fidelity (GO:0006450), positive regulation of DNA-templated transcription (GO:0045893), ‘de novo’ cotranslational protein folding (GO:0051083), regulation of cellular response to heat (GO:1900034), negative regulation of DNA biosynthetic process (GO:2000279), chromatin organization (GO:0006325)

GO Molecular Function (8): ATPase activator activity (GO:0001671), chromatin binding (GO:0003682), RNA binding (GO:0003723), Hsp70 protein binding (GO:0030544), histone binding (GO:0042393), ribosome binding (GO:0043022), ubiquitin-modified histone reader activity (GO:0061649), protein binding (GO:0005515)

GO Cellular Component (6): nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730), cytoplasm (GO:0005737), cytosol (GO:0005829), nuclear membrane (GO:0031965)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Cellular response to heat stress1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
DNA biosynthetic process2
binding2
nuclear lumen2
DNA metabolic process1
regulation of biological quality1
DNA-templated transcription1
regulation of DNA-templated transcription1
positive regulation of RNA biosynthetic process1
‘de novo’ protein folding1
cellular response to heat1
regulation of cellular response to stress1
negative regulation of macromolecule biosynthetic process1
negative regulation of DNA metabolic process1
regulation of DNA biosynthetic process1
cellular component organization1
ATP-dependent activity1
molecular function activator activity1
nucleic acid binding1
heat shock protein binding1
protein-folding chaperone binding1
protein binding1
ribonucleoprotein complex binding1
ubiquitin-modified protein reader activity1
histone reader activity1
intracellular membrane-bounded organelle1
intracellular membraneless organelle1
intracellular anatomical structure1
cytoplasm1
nucleus1
nuclear envelope1
organelle membrane1

Protein interactions and networks

STRING

2588 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DNAJC2HSPA14Q0VDF9982
DNAJC2HSPA4P34932965
DNAJC2DNAJB4Q9UDY4854
DNAJC2HSPA8P11142776
DNAJC2DNAJB1P25685775
DNAJC2RPL31P12947726
DNAJC2B0YIZ1B0YIZ1667
DNAJC2ZPR1O75312646
DNAJC2PDCD11Q14690601
DNAJC2H2AC20Q16777581
DNAJC2H2AC19P20670575
DNAJC2DNAJA1P31689571
DNAJC2ATP2B4P23634566
DNAJC2CCNB1P14635558
DNAJC2DNAJC24Q6P3W2557

IntAct

27 interactions, top by confidence:

ABTypeScore
DNAJC2HSPA14psi-mi:“MI:0915”(physical association)0.670
HSPA14DNAJC2psi-mi:“MI:0914”(association)0.670
H2AC11DNAJC2psi-mi:“MI:0915”(physical association)0.500
DNAJC2H2BC10psi-mi:“MI:0915”(physical association)0.400
DNAJC2ID1psi-mi:“MI:0915”(physical association)0.400
Hspa14TDGpsi-mi:“MI:0914”(association)0.350
SGTBARHGAP32psi-mi:“MI:0914”(association)0.350
H2AC11EEDpsi-mi:“MI:0914”(association)0.350
ESR1ESYT2psi-mi:“MI:0914”(association)0.350
LRRK2psi-mi:“MI:0914”(association)0.350
PAK4SNRPEpsi-mi:“MI:0914”(association)0.350
NEK7SUPT5Hpsi-mi:“MI:0914”(association)0.350
repUQCRBpsi-mi:“MI:0914”(association)0.350
DNAJC2RPS3Apsi-mi:“MI:0914”(association)0.350
DRG1RPS3Apsi-mi:“MI:0914”(association)0.350
HSPA14SURF6psi-mi:“MI:0914”(association)0.350
GTF2E2STX7psi-mi:“MI:0914”(association)0.350
PRKYMETTL15psi-mi:“MI:0914”(association)0.350
HNRNPCL2SMCHD1psi-mi:“MI:0914”(association)0.350
USP47LAMTOR5psi-mi:“MI:0914”(association)0.350
MTPNPLCG1psi-mi:“MI:0914”(association)0.350
SERBP1UBA6psi-mi:“MI:0914”(association)0.350
MND1SH3PXD2Bpsi-mi:“MI:0914”(association)0.350
MILR1SBNO1psi-mi:“MI:0914”(association)0.350

BioGRID (285): DDX5 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNMT1 (Co-fractionation), HSPA14 (Co-fractionation), HSPA4L (Co-fractionation), HYOU1 (Co-fractionation), MYO6 (Co-fractionation), DNAJC2 (Affinity Capture-MS), DNAJC2 (Affinity Capture-MS), DNAJC2 (Affinity Capture-MS)

ESM2 similar proteins: E1C760, E7EXT2, F7AEX0, O00541, O02108, O57476, O94740, P29692, P54103, P79741, P97496, Q16543, Q1RMH9, Q24276, Q24740, Q3B8N8, Q3T095, Q3ZC62, Q4R3D4, Q4R8H2, Q567U6, Q5EAC6, Q5RAS1, Q5RKQ0, Q5ZKI4, Q5ZKM1, Q5ZKY4, Q61081, Q63692, Q640U7, Q68FR9, Q68FU8, Q69ZQ2, Q6AYB3, Q6GQI5, Q6NWJ4, Q6PDG5, Q7TNY6, Q7TQ20, Q7TQK5

Diamond homologs: B8A9B2, F4JVB8, P34454, P54103, Q1A173, Q1G3C4, Q1RMH9, Q4R8H2, Q58FS3, Q6NNN0, Q6NWJ4, Q6P2Y3, Q7TQ20, Q8GW75, Q8LH59, Q8S9H7, Q96KC8, Q99543, Q9FNN6, Q9SIJ5, A0AIS3, A0KMI5, A0Q1R3, A1KR91, A2SIR5, A5EYE5, A6LJ63, A6T4F5, A7Z6W0, A7ZHA5, A7ZVV8, A8FFD1, A9BNG6, A9LZV9, A9MR76, A9MXI3, B1IRF9, B1LFU5, B1XBE0, B1ZUS0

SIGNOR signaling

1 interactions.

AEffectBMechanism
DNAJC2“form complex”“Ribosome-associated complex”binding

Disease & clinical

Clinical variants and AI predictions

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance61
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2128 predictions. Top by Δscore:

VariantEffectΔscore
7:103312937:A:Cdonor_gain1.0000
7:103315759:TTTA:Tdonor_loss1.0000
7:103315760:TTACC:Tdonor_loss1.0000
7:103315761:TACC:Tdonor_loss1.0000
7:103315762:A:Tdonor_loss1.0000
7:103315763:C:CTdonor_loss1.0000
7:103315763:CCTT:Cdonor_gain1.0000
7:103315867:AGGGT:Aacceptor_gain1.0000
7:103315868:GGGT:Gacceptor_gain1.0000
7:103315869:GGT:Gacceptor_gain1.0000
7:103315870:GT:Gacceptor_gain1.0000
7:103315872:C:CCacceptor_gain1.0000
7:103315873:T:Gacceptor_loss1.0000
7:103315879:A:ACacceptor_gain1.0000
7:103315879:A:Cacceptor_gain1.0000
7:103316045:C:CTacceptor_gain1.0000
7:103316046:A:Tacceptor_gain1.0000
7:103316907:T:TAdonor_gain1.0000
7:103319603:TATTA:Tdonor_loss1.0000
7:103319604:ATTAC:Adonor_loss1.0000
7:103319605:TTACC:Tdonor_loss1.0000
7:103319606:TACCT:Tdonor_loss1.0000
7:103319607:ACCT:Adonor_loss1.0000
7:103319608:C:CTdonor_loss1.0000
7:103321927:TATAC:Tdonor_loss1.0000
7:103321930:A:Cdonor_loss1.0000
7:103321931:C:Gdonor_loss1.0000
7:103321955:G:Adonor_gain1.0000
7:103321960:T:TAdonor_gain1.0000
7:103322077:CTTTG:Cacceptor_gain1.0000

AlphaMissense

4130 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:103312639:A:GL599P1.000
7:103312954:C:GR595P1.000
7:103312962:G:CC592W1.000
7:103313007:C:AW577C1.000
7:103313007:C:GW577C1.000
7:103313009:A:GW577R1.000
7:103313009:A:TW577R1.000
7:103313010:T:AR576S1.000
7:103313010:T:GR576S1.000
7:103313045:C:GA565P1.000
7:103313078:A:GW554R1.000
7:103313078:A:TW554R1.000
7:103316020:A:TV499D1.000
7:103316057:G:CH487D1.000
7:103316075:C:GA481P1.000
7:103316077:A:TI480N1.000
7:103316085:C:AW477C1.000
7:103316085:C:GW477C1.000
7:103316086:C:GW477S1.000
7:103316087:A:GW477R1.000
7:103316087:A:TW477R1.000
7:103316088:T:AR476S1.000
7:103316088:T:GR476S1.000
7:103316830:C:AR476I1.000
7:103316830:C:GR476T1.000
7:103316831:T:CR476G1.000
7:103316842:C:TG472E1.000
7:103316843:C:GG472R1.000
7:103316843:C:TG472R1.000
7:103316845:G:TA471D1.000

dbSNP variants (sampled 300 via entrez): RS1000003336 (7:103344183 G>A,C), RS1000267442 (7:103320966 G>C), RS1000273187 (7:103332394 C>T), RS1000442108 (7:103315041 G>A), RS1000465639 (7:103337974 A>C), RS1000498409 (7:103336705 T>C), RS1000514424 (7:103339131 G>A), RS1000638608 (7:103331445 A>G), RS1000784337 (7:103321271 C>T), RS1000907253 (7:103343742 G>A), RS1001033487 (7:103312444 G>A), RS1001157350 (7:103329075 G>A), RS1001202645 (7:103336511 T>C), RS1001212453 (7:103333912 T>C), RS1001283895 (7:103333718 T>A)

Disease associations

OMIM: gene MIM:605502 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009391_944Metabolite levels9.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010402triacylglycerol 46:2 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

40 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects expression, decreases expression2
sodium arsenitedecreases expression, increases activity, affects cotreatment, increases abundance, increases expression2
Estradiolincreases expression2
Tobacco Smoke Pollutionincreases expression2
Cyclosporineincreases expression2
GSK-J4increases expression1
FR900359affects phosphorylation1
dicrotophosdecreases expression1
methylmercuric chlorideincreases expression1
trichostatin Aaffects expression1
cobaltous chlorideincreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
di-n-butylphosphoric acidaffects expression1
2,3,5-(triglutathion-S-yl)hydroquinoneincreases ADP-ribosylation1
perfluoro-n-nonanoic acidincreases expression1
ICG 001decreases expression1
jinfukangdecreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects cotreatment, increases abundance, increases expression1
Benzo(a)pyrenedecreases methylation1
Cadmiumincreases abundance, decreases expression1
Caffeineincreases phosphorylation1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Ivermectindecreases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Mustard Gasincreases phosphorylation1
Phenobarbitalaffects expression1
Quercetindecreases expression1
Ribonucleotidesaffects binding1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2W0Abcam HEK293T DNAJC2 KOTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.